An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Amyloidosis: Diagnosis, Treatment, and Supportive Care 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
What is Optimal First-Line Management of Advanced Classic Hodgkin Lymphoma? 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updates in Prognosis and Treatment 1.00 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Diffuse Large B-Cell Lymphoma: Sequencing Therapy for Relapsed/Refractory Disease 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Debate: Is the Addition of Polatuzumab Vedotin the New Standard First-Line Therapy for Diffuse Large B-Cell Lymphoma? 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Managing Post-Treatment Complications for Multiple Myeloma and Acute Lymphocytic Leukemia 1.00 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Management of Multiple Myeloma: Smoldering, Newly Diagnosed, and Relapsed/Refractory Disease 2.25 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Myelodysplastic Syndromes: Treatment Updates and Emerging Data 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Review of Oral Targeted Therapies in Acute Myeloid Leukemia 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Managing Earlier Integration of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Optimizing the Use of Bispecific Antibodies in Hematologic Malignancies 1.00 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Evaluation and Treatment of Primary Central Nervous System Lymphoma 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Chronic Myeloid Leukemia: How to Treat During Pregnancy 0.25 12/01/2024 - 12:00am to 12/01/2025 - 12:00am

Pages